August 13, 2011
Tis essential to remember, that when the mighty fall, it takes a tad longer, but they crumble all the same.
August 12, 2011 — Swiss implant maker Nobel Biocare reported revenues of 286.4 million euros ($408 million U.S.) for the first half of 2011 (end-June 30), a 1.4% decrease from revenues of 291.6 million euros ($415.9 million) for the same period in 2010.
Net profit for the first half of the year was 28.8 million euros ($41 million), down 50.7% from a net profit of 58.3 million euros ($83 million) for the same period in 2010. The company attributed the decrease primarily to lower operating profits and the non recurrence of exceptional currency gains recorded in the first quarter of 2010.
Your email address will not be published. Required fields are marked *
Save my name, email, and website in this browser for the next time I comment.